Home Cart Sign in  
Chemical Structure| 57378-72-0 Chemical Structure| 57378-72-0

Structure of Isochlorogenic acid C
CAS No.: 57378-72-0

Chemical Structure| 57378-72-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4,5-Dicaffeoylquinic acid (Isochlorogenic acid C) is an antioxidant isolated from Gynura divaricata and Laggera alata. It reduces apoptosis in pancreatic islet cells in type 2 diabetic mice, improves pancreatic function, and shows significant inhibitory activity against yeast α-glucosidase.

Synonyms: 4,5-Dicaffeoylquinic acid; 4,5-DCQA

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Isochlorogenic acid C

CAS No. :57378-72-0
Formula : C25H24O12
M.W : 516.45
SMILES Code : O=C([C@]1(O)C[C@@H](OC(/C=C/C2=CC=C(O)C(O)=C2)=O)[C@@H](OC(/C=C/C3=CC=C(O)C(O)=C3)=O)[C@H](O)C1)O
Synonyms :
4,5-Dicaffeoylquinic acid; 4,5-DCQA
MDL No. :MFCD10566623
InChI Key :UFCLZKMFXSILNL-RVXRWRFUSA-N
Pubchem ID :6474309

Safety of Isochlorogenic acid C

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HepG2/CH-Gal3 cells 750 µM 2 h Monitored lysophagic flux, demonstrating reduced mCherry+/SEpHluorin-Gal3 puncta after LLOMe treatment, reversed by FBXO3 inhibition. Antioxidants (Basel). 2019 Sep 8;8(9):381
HepG2/GFP-Gal3 cells 750 µM 2 h Evaluated clearance of GFP-Gal3 puncta post-lysosomal damage induced by LLOMe, showing FBXO3 inhibition significantly impaired damaged lysosome clearance. Antioxidants (Basel). 2019 Sep 8;8(9):381
HaCaT cells 5, 10, 20 μM 24 hours Evaluate the protective effect of TCQA against UVB-induced oxidative stress, results showed TCQA significantly reduced ROS levels Antioxidants (Basel). 2023 Oct 23;12(10):1899
HaCaT cells 5, 10, 20 μM 24 hours Evaluate the effect of TCQA on the Nrf2–ARE pathway, results showed TCQA significantly increased Nrf2–ARE luciferase activity Antioxidants (Basel). 2023 Oct 23;12(10):1899
RAW264.7 macrophages 1.56-25 μM 18 hours To detect the cholesterol efflux-promoting ability of ICAC, results showed ICAC significantly promoted cholesterol efflux in a dose-dependent manner Front Pharmacol. 2022 Jul 25;13:881078
Bone marrow-derived macrophages (BMMs) 1.56-50 μM 24 hours To evaluate the cytotoxicity of ICAC on BMMs, results showed no significant cytotoxicity at concentrations below 50 μM Front Pharmacol. 2022 Jul 25;13:881078
Human foreskin fibroblasts (HFF-1) 5, 10, 20 µM 24 hours To investigate the protective effect of isochlorogenic acid C against blue light damage, results showed that isochlorogenic acid C at 5, 10, 20 µM significantly promoted COL-I secretion and inhibited MMP-1 secretion. Molecules. 2023 Oct 28;28(21):7319

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Drosophila Transgenic larval fat body Oral 5 mM 2 h treatment, followed by transfer to normal food for 4-8 h Validated the role of TBK1-FBXO3-TMEM192-TAX1BP1 axis in vivo lysophagy, showing impaired clearance of mCherry+/SEpHluorin-Gal3 puncta upon FBXO3 knockdown. Antioxidants (Basel). 2019 Sep 8;8(9):381
C57BL/6 mice High-fat diet-induced hyperlipidemia model 10 mg/kg/d and 20 mg/kg/d Daily administration for 12 weeks To evaluate the lipid-lowering effect of ICAC in HFD-induced hyperlipidemic mice, results showed ICAC significantly reduced lipid levels in serum and liver, and functioned by promoting the RCT pathway in liver and intestine Front Pharmacol. 2022 Jul 25;13:881078

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.94mL

0.39mL

0.19mL

9.68mL

1.94mL

0.97mL

19.36mL

3.87mL

1.94mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories